Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dermal tissue regeneration refers to the process by which the dermal layer of the skin is restored after injury or damage. This process requires the coordinated action of multiple cellular and molecular components, including fibroblasts, keratinocytes, immune cells, extracellular matrix proteins (such as collagen), growth factors (e.g. TGF-β, PDGF, VEGF), and cytokines. The phases of repair typically include inflammation, formation of new tissue (proliferation), extracellular matrix deposition, and remodeling. Regenerative outcomes aim to restore both the structure and function of the dermis while minimizing scarring. Impaired dermal regeneration leads to chronic wounds or excessive scarring, and various therapeutic interventions, including growth factor therapies, stem cell-derived exosomes, and engineered biomaterials, target different components of this regenerative cascade[1][2][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dermal Tissue Regeneration.